Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
191
-
Total 13F shares, excl. options
-
65.1M
-
Shares change
-
-3.74M
-
Total reported value, excl. options
-
$1.47B
-
Value change
-
-$90.1M
-
Put/Call ratio
-
0.1
-
Number of buys
-
86
-
Number of sells
-
-113
-
Price
-
$22.57
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q3 2016
228 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q3 2016.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 191 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.1M shares
of 115M outstanding shares and own 56.5% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (8.65M shares), VANGUARD GROUP INC (5.14M shares), JANUS CAPITAL MANAGEMENT LLC (3.86M shares), OAK RIDGE INVESTMENTS LLC (2.36M shares), Bank of New York Mellon Corp (2.34M shares), Van Berkom & Associates Inc. (2.19M shares), BlackRock Fund Advisors (2.1M shares), ABERDEEN ASSET MANAGEMENT PLC/UK (1.99M shares), Consonance Capital Management LP (1.86M shares), and BlackRock Institutional Trust Company, N.A. (1.81M shares).
This table shows the top 191 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.